Companies: 10,795·Total market cap: $144.5T
Pharvaris N.V.

Pharvaris N.V.

PHVSNASDAQHealthcare● Active
$30.88
$-0.21(-0.68%)
Market Cap$2.2B
P/E Ratio
52W High$33.33
52W Low$15.91
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Pharvaris N.V. (PHVS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001830487 · PHVS · NASDAQ · as of Jun 8, 2026

Filing snapshot

255
Total Filings
144
Latest Form
2026-06-04
Most Recent
2021
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001830487 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-02
Fiscal Year End
Apr 2, 2026
Accession No.
0001830487-26-000013
Primary Document
phvs-20251231.htm
Source: data.sec.gov · CIK 0001830487 · Accession 0001830487-26-000013

Latest Key Filings

6-KQuarterly Report
6-K
2026-05-12
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-11
View
424B5424B5
424B5
2026-05-08
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-03
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-02
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-02
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
Showing 1–15 of 166 filingsForm 4 / 144 hidden· 255 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001830487  |  Exchange: NASDAQ · Healthcare

Pharvaris N.V. (NASDAQ: PHVS) has submitted 255 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001830487, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Pharvaris N.V.'s most comprehensive regulatory disclosure. The most recent Pharvaris N.V. 10-K was filed on 2026-04-02 for fiscal year ending 2026. Historical PHVS 10-K annual reports are available from 2020 through 2026.

Investors researching Pharvaris N.V. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

PHVS SEC Filings · 8 questions

Pharvaris N.V. (PHVS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 255 filings and access original documents at no cost. Pharvaris N.V.'s CIK is 0001830487.

PHVS SEC filingsPharvaris N.V. SEC documentsfind PHVS 10-K